Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects – a preliminary study

Abstract

The brain tumours represent a complex tissue that has its own characteristic metabolic features and is interfaced with the whole organism. We investigated changes in basal blood plasma metabolites in the presence of primary brain tumour, their correlation with tumour grade, as well as the feasibility of statistical discrimination based on plasma metabolites. Together 60 plasma samples from patients with clinically defined glioblastoma, meningioma, oligodendrioglioma, astrocytoma, and non-specific glial tumour and plasma samples from 28 healthy volunteers without any cancer history were measured by NMR spectroscopy. In blood plasma of primary brain tumour patients, we found significantly increased levels of glycolytic metabolites glucose and pyruvate, and significantly decreased level of glutamine and also metabolites participating in tricarboxylic acid (TCA) cycle, citrate and succinate, when compared with controls. Further, plasma metabolites levels: tyrosine, phenylalanine, glucose, creatine and creatinine correlated significantly with tumour grade. In general, observed changes are parallel to the biochemistry expected for tumourous tissue and metabolic changes in plasma seem to follow the similar rules in all primary brain tumours, with very subtle variations among tumour types. Only two plasma metabolites tyrosine and phenylalanine were increased exclusively in

Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas

“…Plasma metabolomics was also used to predict the GBM patient survival, and higher levels of arginine and methionine are correlated with increased probability of survival, while higher levels of kynurenate with decreased probability [ 211 ]. An exploratory plasma NMR metabolomics study indicated that the levels of creatine, citrate, glucose, pyruvate, and glutamine can be used to discriminate between primary brain tumor patients (among them GBM patients) and healthy controls [ 212 ]. In a different approach in glioma patients, the metabolic profile of arterial blood right upstream of a brain tumor was analyzed and compared with venous blood right downstream of the tumor.…”

Undetectable free aromatic amino acids in nails of breast carcinoma: Biomarkers discovery by a novel metabolite purification VTGE system

“…Metabolic dependency and addiction to use the amino acid by cancer cells are known to support self-sustained growth and aggressiveness (23)(24)(25)(26)(27)(28)(29). In case of breast cancer patients, abundance of key amino acids, including FAAA in the other body parts and biological fluids is reduced.…”

“…The determination of metabolite profiling is perceived as one viable option to detect early and late stage physiological and pathological changes in cancer patients (23)(24)(25)(26)(27)(28)(29). In this direction, several attempts are noticed by using metabolomic approaches, including LC-HRMS, GC-MS and NMR spectroscopy.…”

Undetectable Free Aromatic Amino Acids in Nails of Breast Carcinoma: Biomarker Discovery by a Novel Metabolite Purification VTGE System

“…Determination of metabolite profiling was perceived as one viable option to detect early-and late-stage physiological and pathological changes in cancer patients (23)(24)(25)(26)(27)(28)(29). Several attempts were made in this direction by using metabolomic approaches such as LC-HRMS, GC-MS, and NMR spectroscopy.…”